AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Glinil-M Tablet

Prescription Icon
Prescription Required

Marketer

Cipla Ltd

Salt Composition

Glibenclamide (5mg) + Metformin (500mg)

Overview Glinil-M Tablet

DiabetaComb tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose levels. DiabetaComb should be taken with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to complications such as kidney impairment, vision loss, neuropathy, and limb amputation. Remember, DiabetaComb is one component of a comprehensive diabetes management plan, encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar). Learn to identify its symptoms—sweating, dizziness, headache, tremors—and how to treat it promptly. Maintaining regular meals and carrying a readily available fast-acting glucose source (e.g., sugary snacks, fruit juice) is essential. Alcohol consumption should be limited due to its potential to worsen hypoglycemia. Additional possible side effects include nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections; some users may experience weight gain. DiabetaComb is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to check blood cell counts and liver function.

Primary Ingredients of Glinil-M Tablet

There is no text provided to rephrase.

Uses of Glinil-M Tablet

Adult-onset diabetes

Major Benefits of Glinil-M Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Glinil-M Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

Common Side effects of Glinil-M Tablet:

  • Dizziness
  • Diarrhea
  • Nausea
  • Flatulence
  • Headache
  • Upper respiratory tract infection

How to use Glinil-M Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Glinil-M Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

How Glinil-M Tablet works:

Glibenclamide, a sulfonylurea drug, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Glinil-M Tablet use poses a safety risk.

PregnancyPregnancySAFE IF PRESCRIBED

Pregnancy use of Glinil-M tablets is generally deemed safe. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; however, data from human studies are scarce.

Breast feedingBreast feedingCAUTION

Use of Glinil-M tablets while breastfeeding requires careful consideration. Mothers should discontinue breastfeeding until their treatment concludes and the medication is fully cleared from their system.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Glinil-M Tablet on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.

KidneyKidneyUNSAFE

The use of Glinil-M tablets is contraindicated in individuals with renal impairment and should be avoided. Seek medical advice before use.

LiverLiverCAUTION

Patients with hepatic impairment should use Glinil-M tablets judiciously, potentially requiring dosage modification. Physician consultation is advised.

What if you forget to take Glinil-M Tablet :

Should you forget a Glinil-M Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glinil-M Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glinil-M Tablet

Glinil-M tablets combine glibenclamide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glibenclamide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Glinil-M is not suitable for type 1 diabetes.
Type 2 diabetes, the most prevalent form of diabetes, occurs when the body doesn't produce sufficient insulin or the insulin produced is ineffective. This leads to elevated blood glucose levels, causing various health issues. High blood sugar symptoms include frequent urination, excessive thirst, and increased hunger. Untreated, type 2 diabetes can result in long-term complications such as nerve damage (neuropathy), kidney damage (nephropathy), eye damage (retinopathy), foot problems, and an increased risk of heart disease.
Glinil-M Tablet may cause common side effects such as hypoglycemia, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Glinil-M Tablets can cause low blood sugar (hypoglycemia), with symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Prolonged Glinil-M Tablet use can interfere with vitamin B12 absorption, potentially leading to deficiency. This deficiency, if left untreated, may cause anemia, nerve damage (including tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glinil-M Tablets are contraindicated in patients with known allergies to any ingredient, those with moderate to severe kidney disease, and those with underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Glinil-M tablets and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and increased lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glinil-M tablets combine glibenclamide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glibenclamide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Glinil-M is not suitable for type 1 diabetes.
Type 2 diabetes, the most prevalent form of diabetes, occurs when the body doesn't produce sufficient insulin or the insulin produced is ineffective. This results in elevated blood glucose, causing various health issues. Symptoms include excessive thirst, frequent urination, and increased hunger. Untreated, type 2 diabetes can lead to serious long-term complications such as nerve damage (neuropathy), kidney damage (nephropathy), eye damage (retinopathy), foot problems, and a heightened risk of heart disease.
Glinil-M Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Glinil-M Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Prolonged Glinil-M Tablet use can interfere with vitamin B12 absorption, potentially leading to deficiency. This deficiency, if left untreated, may cause anemia, neurological issues such as numbness, tingling in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glinil-M Tablets are contraindicated in patients allergic to any component or excipient. Avoid use in patients with moderate to severe kidney disease or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Glinil-M tablets and alcohol is unsafe, as it can dangerously lower blood sugar and raise the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glinil-M Tablet
30
MRP 34
12% off